We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Dedicated to our clients' success
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
Novaremed AG, a privately held clinical-stage biopharmaceutical company and NeuroFront Therapeutics (Hong Kong) Limited, a China-based clinical stage neuroscience biotech company, jointly announced the signing of an exclusive collaboration and commercialization agreement for Novaremed’s innovative non-opioid investigational drug, NRD.E1, being developed for the treatment of diabetes-related neuropathic pain and other neuropathic pain indications.
Cruise Center AG, a Swiss company that has been selling cruises for over twenty years, was acquired by the cruise agency e-hoi with retroactive effect from 1 January 2022.
ImmunOs Therapeutics AG has agreed to a CHF 74 million Series B financing led by incoming co-lead investors Samsara Biocapital, Lightspeed Venture Partners and Gimv, corner-stoned by GL Capital, Mission BioCapital, Peak 6 Strategic Capital and Fiscus Financial
Andean Telecom Partners ("ATP"), a leading owner and operator of telecommunications infrastructure in the Andean Region, acquired BTS Towers ("BTS"), a privately owned provider of telecommunications infrastructure, headquartered...
On January 24, 2022, Kering entered into an agreement for the sale of its entire stake (100%) in Sowind Group SA, which owns the Swiss watch manufacturers Girard-Perregaux and Ulysse Nardin, to its current management.
VISCHER...
Funds advised by Gilde Buy Out Partners, a leading European private equity investor, completed the investment in MBK Fincom ("MBK" or the "Company"), alongside the founders and management which are reinvesting in the business....
NEMIS Technologies AG closed a CHF 7.75m Series A financing round with the participation of both institutional and private investors.
A group of investors advised by Rigeto Unternehmerkapital GmbH has acquired 100% of the shares in Laser Beauté Med SA, headquartered in Sion with additional locations in Monthey and Visp.
deepCDR Biologics AG, ein in Basel ansässiges Start-Up, das sich auf die Entdeckung und Entwicklung von Antikörpern spezialisiert hat, wurde von Alloy Therapeutics Inc., ein in Boston ansässiges Biotechnologieunternehmen, übernommen.
Orell Füssli Thalia AG acquired a stake as Lead Investor in the digital community platform Evrlearn AG.
Displaying results 41 to 50 out of 166